Deschloroetizolam

Last updated

Deschloroetizolam
Deschloroetizolam.svg
Deschloroetizolam.png
Clinical data
Dependence
liability
Moderate
Routes of
administration
Oral, sublingual, rectal
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class C
  • Illegal in Sweden
Identifiers
  • 4-phenyl-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
Formula C17H16N4S
Molar mass 308.40 g·mol−1
3D model (JSmol)
  • CCC1=CC2=C(S1)N3C(=NN=C3CN=C2C4=CC=CC=C4)C
  • InChI=1S/C17H16N4S/c1-3-13-9-14-16(12-7-5-4-6-8-12)18-10-15-20-19-11(2)21(15)17(14)22-13/h4-9H,3,10H2,1-2H3
  • Key:JIOBORXCOGMHSV-UHFFFAOYSA-N

Deschloroetizolam (also known as Etizolam-2) is a thienotriazolodiazepine that is the dechlorinated analog of the closely related etizolam. [1] [2] [3] The compound has been sold as a designer drug. [4] [5] [6]

Contents

Deschloroetizolam is classified and controlled as a hazardous substance in Sweden as of on October 15, 2015. [7]

Deschloroetizolam was made schedule I at the state level in Alabama on July 15, 2024. [8]

See also

References

  1. Weber KH, Bauer A, Langbein A, Daniel H (September 1978). "Heteroaromaten mit anellierten Siebenringen, III. Umwandlung von Thienotriazolooxazepinen in Diazepine". Justus Liebigs Annalen der Chemie (in German). 1978 (8): 1257–1265. doi:10.1002/jlac.197819780806.
  2. US 3904641,Nakanishi M, Tahara T, Araki K, Shiroki M,"Triazolothienodiazepine compounds",published 1975-09-09, assigned to Yoshitomi Pharmaceutical Industries, Ltd.
  3. EP 0776892,Hiroshi K, Syuji E, Hideaki S, Minoru M, Kenichi O,"Thienylazole compound and thienotriazolodiazepine compound",published 4 June 1997, assigned to Yoshitomi Pharmaceutical Industries, Ltd.
  4. Pettersson Bergstrand M, Helander A, Hansson T, Beck O (April 2017). "Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays". Drug Testing and Analysis. 9 (4): 640–645. doi:10.1002/dta.2003. PMID   27366870.
  5. Manchester KR, Maskell PD, Waters L (March 2018). "Experimental versus theoretical log D7.4 , pKa and plasma protein binding values for benzodiazepines appearing as new psychoactive substances". Drug Testing and Analysis. 10 (8): 1258–1269. doi:10.1002/dta.2387. PMID   29582576. S2CID   31098917.
  6. Manchester KR, Waters L, Haider S, Maskell PD (July 2022). "The blood-to-plasma ratio and predicted GABAA-binding affinity of designer benzodiazepines". Forensic Toxicology. 40 (2): 349–356. doi:10.1007/s11419-022-00616-y. PMC   9715504 . PMID   36454409. S2CID   247455284.
  7. "Nya substanser klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. 18 August 2015.
  8. "Controlled Substances List" (PDF). alabamapublichealth.gov. January 16, 2025. Retrieved 12 Nov 2025.